리가켐바이오

141080KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

69,900KRWMarket close of 10/20 (Tue)

Down -1.41%-1,000KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)71,300KRWUp +2.00%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
69,200
High
71,700
Low
67,700
Day range
Day range low 67,700 high 71,700, open 69,200, close 69,900, previous close 70,900
Volume
17×10K shares
12.1B KRW 0.74× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 62,800 to 213,500 won, 5% up from the low

5% of the way up from the lowest close in 1 year (252 sessions) · -67.3% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-205.7B KRWOperating income over the last four quarters -205.7B KRW (loss)Operating income, 8 quarters
  • Daily moveusual range-1.41%-1.41%, 0.4× the usual (20-session average ±3.32%)
    That day -1.41% · usual ±3.32% · large-move threshold ±6.6%
  • Trading valueusual range0.7×12.1B KRW, 0.7× the 20-session average
    0.74× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+9.9B KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW
바이오인프라Close over the last 20 sessions +123.3%Down -6.80%9.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.